To The Moon

$Vaccinex Inc.(VCNX)$  is my next choice to pop. I am very happy too see new treatment work, but most biotech companies fail . I invested in Humanigen, and now they are worth just over 1 million USD and almost bankrupt. I expect only one out of ten start up companies and biotech investments to give me a decent return.  The rest will flounder away or break even if I am lucky.  But it you find that one unicorn of an investment it can reward you very well.  So take your time and have a coffee before you decide to Invest your hard earned money. 

$Tempest Therapeutics Inc.(TPST)$ . Awesome research work hard. Beautiful 

$Tempest Therapeutics Inc.(TPST)$ More TPST type stocks to come will be good.. 

Hmm i dont know, but this post is a robbery, cheers

The market for weight loss drugs is big, but the changes for all of us are significant. ozempic and Ely Lilly's $Eli Lilly(LLY)$ future weight loss drugs will reduce the amount of calories we consume on average per day. The same drug will also eliminate many lifestyle diseases, and keep us all in the labor market for several extra years. These changes because of the drugs will have an impact - McDonalds falls in value, and we get more jobs filled, because of fewer sick people? (Just to mention a few examples) Which stocks are good to buy now, with these changes coming anytime soon? $Tempest Therapeutics Inc.(TPST)$

Oh man, this is some juicy stuff about the weight loss drug industry and how it's affecting the stock market. Walmart's big boss, John Furner, spilled the beans in an interview with Bloomberg, saying they've noticed a "slight change" in the eating habits of folks taking Ozempic and other weight loss drugs, compared to those who aren't popping these magic pills. It's like the impact of these pills is rippling through the business world!Now, these weight loss drugs, Ozempic, and Wegovy, they've been all the rage lately, and it's no surprise why. They work by making you feel less hungry – they mimic some fancy hormone that tells your brain, "Hey, you're full, stop stuffing your face!" UC Davis Health says it's all about that hormone game.And guess what? They're even making people less interes

The recent meteoric rise of Tempest Therapeutics Inc. has sent shockwaves through the investment landscape, reminiscent of previous market frenzies surrounding GameStop, AMC, and cryptocurrency. While the surge in stock value was triggered by promising study results for its cancer treatment TPST-1120, it’s essential to approach such hype stocks with caution, considering the underlying investing fundamentals and the potential risks associated with volatile market surges. $Tempest Therapeutics Inc.(TPST)$  1. Tempest Therapeutics’ Spectacular Surge: The Study Results and Stockholder Rights Plan • Shares of Tempest Therapeutics skyrocketed by an unprecedented 4,000% following the announcement of positive study results for its investigational ca

$Tempest Therapeutics Inc.(TPST)$   The world of investing is often a thrilling rollercoaster ride, with stocks surging and plummeting at a moment's notice. One such recent surge that has caught my attention is Tempest, a company in the biotech sector. The question on many minds is whether to trade this meme biotech stock and whether their treatment could potentially revolutionize liver cancer care. First, let's address the surge of Tempest. I can't help but be intrigued by the rapid rise of this biotech stock. Meme stocks tend to garner attention due to their sudden price fluctuations driven by social media hype and investor sentiment. However, it's crucial to approach them with caution, considering their inherent volatility. While the surge

$Tempest Therapeutics Inc.(TPST)$ Then what's going on🫠

Founded in 2011, California-based $Tempest Therapeutics Inc.(TPST)$ deals primarily in developing treatments for cancer patients.The cancer therapies company surged 4000% during the trading hours after it reported positive results for its TPST-1120 drug candidate in clinical study. HCC (Hepatocellular Carcinoma) is an aggressive cancer, with over 900,000 people diagnosed worldwide every year. Furthermore, it is projected to become the third leading cause of cancer-related deaths by 2030.Clinical trial shows significant progress of its drug in treating liver cancerTempest conducted the study that sent TPST stock up in conjunction with Swiss healthcare company $Roche Holding Ltd(RHHBY)

$Tempest Therapeutics Inc.(TPST)$ I want to share my feeling with all of you!I tell myself not to buy PM pumps but Cancer Cure and SP moved from .27 was at .84 when I bought All day I watched it climb pull back and climb some more and of course 20 sum Halts! One hell of a feeling turning 11k into 126k!Haha! Now let’s come into the stock and the company. $Tempest Therapeutics Inc.(TPST)$ Roche (atezolizumab) used for first line HCC does $4 billion in sales annually and growing. If TPST-1120 improves it as the Tempest study has indicated, they simply can’t let it fall into competitors hands. Would be interesting though to see how well it pairs with $Merck(MRK)$ Keyt

Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-class1 therapeutics that combine both targeted and immune-mediated mechanisms, today announced new and updated positive results from the planned data analysis of an ongoing global randomized Phase 1b/2 clinical study in which TPST-1120, Tempest’s PPAR⍺ antagonist, shows clinical superiority in multiple study endpoints when combined with atezolizumab and bevacizumab in a randomized comparison to atezolizumab and bevacizumab in the first-line treatment of patients with unresectable or metastatic hepatocellular carcinoma (“HCC”).Tempest Therapeutics shares jumped 700% in premarket trading.“This comprehensive analysis of more mature clinical data shows an even greater benefit than the earlier inter

The recent meteoric rise of Tempest Therapeutics Inc. has sent shockwaves through the investment landscape, reminiscent of previous market frenzies surrounding GameStop, AMC, and cryptocurrency. While the surge in stock value was triggered by promising study results for its cancer treatment TPST-1120, it’s essential to approach such hype stocks with caution, considering the underlying investing fundamentals and the potential risks associated with volatile market surges. $Tempest Therapeutics Inc.(TPST)$  1. Tempest Therapeutics’ Spectacular Surge: The Study Results and Stockholder Rights Plan • Shares of Tempest Therapeutics skyrocketed by an unprecedented 4,000% following the announcement of positive study results for its investigational ca

Founded in 2011, California-based $Tempest Therapeutics Inc.(TPST)$ deals primarily in developing treatments for cancer patients.The cancer therapies company surged 4000% during the trading hours after it reported positive results for its TPST-1120 drug candidate in clinical study. HCC (Hepatocellular Carcinoma) is an aggressive cancer, with over 900,000 people diagnosed worldwide every year. Furthermore, it is projected to become the third leading cause of cancer-related deaths by 2030.Clinical trial shows significant progress of its drug in treating liver cancerTempest conducted the study that sent TPST stock up in conjunction with Swiss healthcare company $Roche Holding Ltd(RHHBY)

$Tempest Therapeutics Inc.(TPST)$   The world of investing is often a thrilling rollercoaster ride, with stocks surging and plummeting at a moment's notice. One such recent surge that has caught my attention is Tempest, a company in the biotech sector. The question on many minds is whether to trade this meme biotech stock and whether their treatment could potentially revolutionize liver cancer care. First, let's address the surge of Tempest. I can't help but be intrigued by the rapid rise of this biotech stock. Meme stocks tend to garner attention due to their sudden price fluctuations driven by social media hype and investor sentiment. However, it's crucial to approach them with caution, considering their inherent volatility. While the surge

Oh man, this is some juicy stuff about the weight loss drug industry and how it's affecting the stock market. Walmart's big boss, John Furner, spilled the beans in an interview with Bloomberg, saying they've noticed a "slight change" in the eating habits of folks taking Ozempic and other weight loss drugs, compared to those who aren't popping these magic pills. It's like the impact of these pills is rippling through the business world!Now, these weight loss drugs, Ozempic, and Wegovy, they've been all the rage lately, and it's no surprise why. They work by making you feel less hungry – they mimic some fancy hormone that tells your brain, "Hey, you're full, stop stuffing your face!" UC Davis Health says it's all about that hormone game.And guess what? They're even making people less interes

Shares of Tempest Therapeutics soared 1067% in morning trading Wednesday after the clinical-stage oncology company reported positive study results for its TPST-1120 drug candidate in the most common type of primary liver cancer and adopted a shareholder rights plan.Tempest on Wednesday said new data showed clinical superiority in multiple study endpoints for TPST-1120 combined with the Roche Holdings cancer drugs Avastin and Tecentriq versus the two Roche drugs alone in a global Phase 1b/2 study.The Brisbane, Calif., company said the data include a confirmed objective response rate of 30% for the TPST-1120 triplet arm, compared with 13.3% for the Avastin/Tecentriq control arm.Roche is managing the study under a 2021 collaboration, while Tempest retains all product rights to TPST-1120.Tempe

$Tempest Therapeutics Inc.(TPST)$ Shorts trying to take a scenario they have never seen before and apply useless data that isn’t relevant to what this stock is really worth.. The price can tell you anything they want as long as they make money on the short side..This stock is moving up! This stock is a unicorn!100 million market cap. The cost of the Roche treatment (used together with TPST-1120) alone costs $322k a year. There are 800k people diagnosed with liver cancer every year, 700k die from it annually.But TPST made a huge progress here! From the Ppt & confirmed call, the confirmed objective response rate (cORR or confirmed ORR) was 30% for the TPST-1120 triplet arm (ie versus 13.3% for the atezolizumab + bevaciz

$Tempest Therapeutics Inc.(TPST)$ I want to share my feeling with all of you!I tell myself not to buy PM pumps but Cancer Cure and SP moved from .27 was at .84 when I bought All day I watched it climb pull back and climb some more and of course 20 sum Halts! One hell of a feeling turning 11k into 126k!Haha! Now let’s come into the stock and the company. $Tempest Therapeutics Inc.(TPST)$ Roche (atezolizumab) used for first line HCC does $4 billion in sales annually and growing. If TPST-1120 improves it as the Tempest study has indicated, they simply can’t let it fall into competitors hands. Would be interesting though to see how well it pairs with $Merck(MRK)$ Keyt

$Vaccinex Inc.(VCNX)$  is my next choice to pop. I am very happy too see new treatment work, but most biotech companies fail . I invested in Humanigen, and now they are worth just over 1 million USD and almost bankrupt. I expect only one out of ten start up companies and biotech investments to give me a decent return.  The rest will flounder away or break even if I am lucky.  But it you find that one unicorn of an investment it can reward you very well.  So take your time and have a coffee before you decide to Invest your hard earned money. 

The market for weight loss drugs is big, but the changes for all of us are significant. ozempic and Ely Lilly's $Eli Lilly(LLY)$ future weight loss drugs will reduce the amount of calories we consume on average per day. The same drug will also eliminate many lifestyle diseases, and keep us all in the labor market for several extra years. These changes because of the drugs will have an impact - McDonalds falls in value, and we get more jobs filled, because of fewer sick people? (Just to mention a few examples) Which stocks are good to buy now, with these changes coming anytime soon? $Tempest Therapeutics Inc.(TPST)$

$Tempest Therapeutics Inc.(TPST)$ More TPST type stocks to come will be good.. 

$Tempest Therapeutics Inc.(TPST)$ . Awesome research work hard. Beautiful 

$Tempest Therapeutics Inc.(TPST)$ Another opportunity ?[DOGE]  

$Tempest Therapeutics Inc.(TPST)$ Buy for another run tomorrow 

$Tempest Therapeutics Inc.(TPST)$ Then what's going on🫠

Hmm i dont know, but this post is a robbery, cheers